[1]
Rukaiah Fatma Begam et al. 2022. A Cross-sectional Study Highlighting Awareness about FDA Announcement on Voluntary Recall of Ranitidine among Physicians and Pharmacists in and Around Chennai, India. Current Aspects in Pharmaceutical Research and Development Vol. 8. (Feb. 2022), 116–127. DOI:https://doi.org/10.9734/bpi/caprd/v8/1776B.